Literature DB >> 24918644

Effect of high-dose irradiation on human bone-marrow-derived mesenchymal stromal cells.

Natalie Fekete1, Alexander Erle, Elisa Maria Amann, Daniel Fürst, Markus Thomas Rojewski, Alain Langonné, Luc Sensebé, Hubert Schrezenmeier, Gerlinde Schmidtke-Schrezenmeier.   

Abstract

Cell therapy using multipotent mesenchymal stromal cells (MSCs) is of high interest in various indications. As the pleiotropic effects mediated by MSCs rely mostly on their unique secretory profile, long-term persistence of ex-vivo-expanded cells in the recipient may not always be desirable. Irradiation is a routine procedure in transfusion medicine to prevent long-term persistence of nucleated cells and could therefore also be applied to MSCs. We have exposed human bone-marrow-derived MSCs to 30 or 60 Gy of γ-irradiation and assessed cell proliferation, clonogenicity, differentiation, cytokine levels in media supernatants, surface receptor profile, as well as expression of proto-oncogenes/cell cycle markers, self-renewal/stemness markers, and DNA damage/irradiation markers. Irradiated MSCs show a significant decrease in proliferation and colony-forming unit-fibroblasts. However, a subpopulation of surviving cells is able to differentiate, but is unable to form colonies after irradiation. Irradiated MSCs showed stable expression of CD73 and CD90 and absence of CD3, CD34, and CD45 during a 16-week follow-up period. We found increased vascular endothelial growth factor (VEGF) levels and a decrease of platelet-derived growth factor (PDGF)-AA and PDGF-AB/BB in culture media of nonirradiated cells. Irradiated MSCs showed an inverse pattern, that is, no increase of VEGF, and less consumption of PDGF-AA and PDGF-AB/BB. Interestingly, interleukin-6 (IL-6) levels increased during culture regardless of irradiation. Cells with lower sensitivity toward γ-irradiation showed positive β-galactosidase activity 10 days after irradiation. Gene expression of both irradiated and nonirradiated MSCs 13-16 weeks after irradiation with 60 Gy predominantly followed the same pattern; cell cycle regulators CDKN1A (p21) and CDKN2A (p16) were upregulated, indicating cell cycle arrest, whereas classical proto-oncogenes, respectively, and self-renewal/stemness markers MYC, TP53 (p53), and KLF4 were downregulated. In addition, DNA damage/irradiation markers ATM, ATR, BRCA1, CHEK1, CHEK2, MDC1, and TP53BP1 also mostly showed the same pattern of gene expression as high-dose γ-irradiation. In conclusion, we demonstrated the existence of an MSC subpopulation with remarkable resistance to high-dose γ-irradiation. Cells surviving irradiation retained their trilineage differentiation capacity and surface marker profile but changed their cytokine secretion profile and became prematurely senescent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24918644      PMCID: PMC4313408          DOI: 10.1089/ten.TEC.2013.0766

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  22 in total

1.  Extracellular matrix and radiation G1 cell cycle arrest in human fibroblasts.

Authors:  M Dimitrijevic-Bussod; V S Balzaretti-Maggi; D M Gadbois
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

2.  Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate.

Authors:  C M Digirolamo; D Stokes; D Colter; D G Phinney; R Class; D J Prockop
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

Review 3.  Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.

Authors:  Aziz Sancar; Laura A Lindsey-Boltz; Keziban Unsal-Kaçmaz; Stuart Linn
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

4.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

5.  Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.

Authors:  Jean-Philippe Coppé; Francis Rodier; Christopher K Patil; Adam Freund; Pierre-Yves Desprez; Judith Campisi
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

6.  Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.

Authors:  Farida Djouad; Pascale Plence; Claire Bony; Philippe Tropel; Florence Apparailly; Jacques Sany; Danièle Noël; Christian Jorgensen
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

7.  Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.

Authors:  Melissa A Baxter; Robert F Wynn; Simon N Jowitt; J Ed Wraith; Leslie J Fairbairn; Ilaria Bellantuono
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

8.  Differential mechanical response of mesenchymal stem cells and fibroblasts to tumor-secreted soluble factors.

Authors:  Daniel J McGrail; Deepraj Ghosh; Nhat D Quach; Michelle R Dawson
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

9.  Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells.

Authors:  J Hou; Z-p Han; Y-y Jing; X Yang; S-s Zhang; K Sun; C Hao; Y Meng; F-h Yu; X-q Liu; Y-f Shi; M-c Wu; L Zhang; L-x Wei
Journal:  Cell Death Dis       Date:  2013-10-10       Impact factor: 8.469

10.  GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC.

Authors:  Natalie Fekete; Markus T Rojewski; Daniel Fürst; Ludwika Kreja; Anita Ignatius; Julia Dausend; Hubert Schrezenmeier
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more
  17 in total

1.  Impact of 2 Gy γ-irradiation on the hallmark characteristics of human bone marrow-derived MSCs.

Authors:  Masaki Iwasa; Sumie Fujii; Aya Fujishiro; Taira Maekawa; Akira Andoh; Akifumi Takaori-Kondo; Tatsuo Ichinohe; Yasuo Miura
Journal:  Int J Hematol       Date:  2021-01-01       Impact factor: 2.490

2.  Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.

Authors:  Zyrafete Kuçi; Halvard Bönig; Hermann Kreyenberg; Milica Bunos; Anna Jauch; Johannes W G Janssen; Marijana Škifić; Kristina Michel; Ben Eising; Giovanna Lucchini; Shahrzad Bakhtiar; Johann Greil; Peter Lang; Oliver Basu; Irene von Luettichau; Ansgar Schulz; Karl-Walter Sykora; Andrea Jarisch; Jan Soerensen; Emilia Salzmann-Manrique; Erhard Seifried; Thomas Klingebiel; Peter Bader; Selim Kuçi
Journal:  Haematologica       Date:  2016-05-12       Impact factor: 9.941

3.  CR6-interacting factor-1 contributes to osteoclastogenesis by inducing receptor activator of nuclear factor κB ligand after radiation.

Authors:  Li-Xin Xiang; Qian Ran; Li Chen; Yang Xiang; Feng-Jie Li; Xiao-Mei Zhang; Yan-Ni Xiao; Ling-Yun Zou; Jiang F Zhong; Shengwen Calvin Li; Zhong-Jun Li
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

4.  Low dose radiation induced senescence of human mesenchymal stromal cells and impaired the autophagy process.

Authors:  Nicola Alessio; Stefania Del Gaudio; Stefania Capasso; Giovanni Di Bernardo; Salvatore Cappabianca; Marilena Cipollaro; Gianfranco Peluso; Umberto Galderisi
Journal:  Oncotarget       Date:  2015-04-10

Review 5.  Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic.

Authors:  Nils H Nicolay; Ramon Lopez Perez; Rainer Saffrich; Peter E Huber
Journal:  Oncotarget       Date:  2015-08-14

6.  Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia but Not Generally Dependent on p53-Regulated Cell Cycle Arrest.

Authors:  Jana Lützkendorf; Elisabeth Wieduwild; Katrin Nerger; Nina Lambrecht; Hans-Joachim Schmoll; Carsten Müller-Tidow; Lutz Peter Müller
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

7.  Human mesenchymal stem cells lose their functional properties after paclitaxel treatment.

Authors:  Franziska Münz; Ramon Lopez Perez; Thuy Trinh; Sonevisay Sisombath; Klaus-Josef Weber; Patrick Wuchter; Jürgen Debus; Rainer Saffrich; Peter E Huber; Nils H Nicolay
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

8.  A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage.

Authors:  Colette Dezutter-Dambuyant; Isabelle Durand; Laurent Alberti; Nathalie Bendriss-Vermare; Jenny Valladeau-Guilemond; Adeline Duc; Audrey Magron; Anne-Pierre Morel; Vanja Sisirak; Céline Rodriguez; David Cox; Daniel Olive; Christophe Caux
Journal:  Oncoimmunology       Date:  2015-10-29       Impact factor: 8.110

9.  Adipose-Derived Mesenchymal Stem Cell Features in Patients with a History of Head and Neck Radiation.

Authors:  Serban San-Marina; Steve Voss; Ruben Crespo-Diaz; Cody Wyles; Atta Behfar; Paul Stalboeger; Jeffrey R Janus
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-06-10

10.  Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells.

Authors:  Doan C Nguyen; Holly C Lewis; Chester Joyner; Vivien Warren; Haopeng Xiao; Haydn T Kissick; Ronghu Wu; Jacques Galipeau; F Eun-Hyung Lee
Journal:  J Extracell Vesicles       Date:  2018-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.